Blog

Today, only dextroamphetamine, lisdexamfetamine, methylphenidate and mixed salts amphetamine are made for medical use. These drugs are used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adults. When amphetamines are used at higher doses and through routes that are not prescribed by a doctor, they can have severe adverse effects. Additionally, medications are used to help people detoxify from drugs, although detoxification is not the same as treatment and is not sufficient to help a person recover. Detoxification alone without subsequent treatment generally leads to resumption of drug use. The chronic nature of addiction means that for some people relapse, or a return to drug use after an attempt to stop, can be part of the process, but newer treatments are designed to help with relapse prevention.

1. Amphetamines were first introduced in the 1930s as a remedy for nasal congestion, and marketed over-the-counter as an inhaler named Benzedrine.
2. In terms of BCBT, some studies reported that patients experienced significant reductions in the severity of amphetamine dependence, substance dependence and improved social functioning [20–23].
3. No tests can determine drug misuse or addiction, but a medical professional can discuss a person’s substance use with them and assess possible risk factors that support the possibility.
4. This was an iterative process where CGC subcommittees drafted recommendations, and a review and discussion of the evidence profile and clinical considerations might have led the CGC to revise the recommendation.

What Is Amphetamine Addiction, Tolerance, and Dependence?

Finally, the accessibility of such treatments remains difficult for a large proportion of patients in the community [8]. Therefore, brief cognitive-behavioural therapy (BCBT) has been introduced by Baker and colleagues for treating amphetamines abuse/use disorder to overcome these operational barriers to implementation [9]. Pharmacological treatments combined with BCBT remain cost-effective for drug treatment systems, due to the limited number of treatment sessions and the efficacy of use [9]. Moreover, high quality in implementing the treatment can be ensured due to tailoring the treatment to the needs of each individual [9]. Furthermore, using pharmacological treatments combined with BCBT is applicable to a broad range of patients due to the practical techniques and skills that such therapies impart to patients [10].

Amphetamine-Related Psychiatric Disorders

They may be whitish with traces of gray or pink and may be a coarse powder, or in crystals or chunks. According to the authors, side effects were minimal, and no drug dependency was seen. However, in the 1950s and 1960s, amid growing concern about its adverse effects, it was replaced by newly available antidepressants. Amphetamines and amphetamine derivatives have been used in the past to treat narcolepsy. In a person with this condition, strong emotions can trigger a sudden loss of muscle tone, or cataplexy, which causes a person to collapse and possibly fall down.

References to other published versions of this review

Methamphetamine causes increased activity, decreased appetite, and a general sense of well-being. After the initial rush, there is typically a state of high agitation that in some individuals may lead to violent behavior. They run the community health van that goes into neighborhoods and test drugs on the spot, potentially preventing overdoses.

In animal studies, methamphetamine increased viral replication; in human methamphetamine abusers, HIV caused greater neuronal injury and cognitive impairment compared with non-drug abusers. Panels used in acute care settings should ideally test for regionally or demographically prevalent stimulants rather than screening for every testable stimulant. It is critical to keep in mind that a negative test result only confirms that the particular target of the test was not detected in the sample. Immunoassays for the cocaine metabolite, benzoylecgonine, have high sensitivity and specificity, whereas available immunoassays for amphetamines have lower specificity and often require confirmatory testing. Clinicians should consider CM to incentivize attendance at prenatal appointments, if feasible, in addition to usual targets (eg, stimulant abstinence). Clinicians should counsel parents/guardians not to conduct drug tests at home to assess stimulant use in adolescents and young adults without the oversight of a trained clinician.

Doctors prescribe amphetamines for conditions such as ADHD, obesity, narcolepsy, and depression. Misusing amphetamines, or taking them in a different way than a doctor prescribes, can lead to how long does weed stay in your system. In certain cases, psychotic symptoms can last for months or years after methamphetamine abuse has ceased.

When legally prescribed, they are typically used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. When education is paired with other harm reduction practices, evidence is strong for a variety of outcomes. The CGC emphasized that education is an important component of change and relatively easy to implement; the importance of patient education is readily supported across a range of other medical conditions. Therefore, clinicians should provide education to patients who use stimulants nonmedically, particularly with respect to safer stimulant use, injection practices, sexual practices, and overdose prevention.

When the draft Guideline was sent out for public comment, it was sent to these and other patient advocacy organizations, but no feedback was received. The CGC recognizes that new strategies are required to effectively engage with patient stakeholders in this work. ASAM and AAAP will continue to iteratively explore new strategies for patient engagement in the development of CPGs. This Guideline is intended to aid clinicians in their clinical decision-making and patient management. It strives to identify and define clinical decision-making junctures that meet the needs of most patients in most circumstances. Clinical decision-making should consider the quality and availability of expertise and services in the community wherein care is provided.

Clinicians should counsel parents/guardians to not conduct drug tests at home to assess stimulant use in adolescents and young adults without this oversight. When prescribing stimulant medications, clinicians should monitor for adverse effects, including secondary hypertension and other cardiac outcomes. Preexisting hypertension, cardiovascular disease, or psychosis should prompt greater caution in using psychostimulants to treat ADHD in StUD. For cocaine use disorder, the certainty of the evidence was judged to be modest given that CRA did not outperform other treatments in all studies.42,64 However, the quality of the evidence favoring CRA is high, coming from well-conducted randomized controlled trials (RCTs). Despite its effectiveness, CM is not widely implemented; less than 10% of addiction treatment programs utilize CM.47 Barriers to implementing CM include regulatory obstacles, financial costs, stakeholder buy-in, and program resources.

A person may need treatment in a therapeutic community in which they will stay at a residence for a long period. A person should seek professional help if they have concerns about their mental health. Prescription drug monitoring programs track the prescribing and dispensing of controlled medications to people.

While both medications are available in generic formulations, the combination would more likely be prescribed by an addiction specialist, potentially limiting access and increasing health inequities. Despite these potential barriers, the CGC concluded that in certain patients, this treatment option may be useful in reducing cocaine use and other co-occurring symptoms. The trials above evaluated injectable—but not oral—naltrexone in combination with bupropion for treatment of StUD. While clinical trials have evaluated both oral and injectable formulations of naltrexone for ATS use disorder, oral naltrexone has not been studied in combination with bupropion.119,120 At the time of this publication, bupropion and oral naltrexone are available in generic formulations. The CGC noted that there is no reason to believe that oral naltrexone would be less effective in this population if the patient is adherent to treatment, although injectable medications can facilitate adherence. Given the potential challenges with access to injectable naltrexone, consideration of combination bupropion and oral naltrexone would be reasonable, particularly for patients who are highly motivated.

Although the context is different, the medical workup of patients who misuse stimulants but do not meet the diagnostic criteria for StUD is similar to that for StUD. For patients who screen positive for stimulant misuse, clinicians should conduct a focused history and clinical exam to evaluate for complications of use related to route of administration and type of preparation used and provide treatment or referrals as appropriate. The consensus of the CGC was that a seizure is well-explained by substance use or withdrawal when, for example, the patient is known to use medications that lower seizure threshold (eg, tramadol, bupropion) or has a history of stimulant- or other substance use-related seizure. In these instances, there is no evidence that a full neurological workup, which requires significant healthcare resources, is of benefit.

For subjective outcomes (global state, craving, and withdrawal symptoms), blindness of participants, personnel, and outcome assessors were conducted in only one study and was determined to be at low risk of bias. In two studies, it was unclear if the outcome assessors were blinded in addition to the applying buddhism in addiction recovery participants and personnel. One study did not specify any method of blinding and was determined to be at unclear risk of bias. Amphetamine-related psychiatric disorders can occur with acute or chronic use. Acute amphetamine use with resultant psychosis can present like a sympathomimetic toxidrome.

Care should be coordinated when patients are receiving concurrent care for a co-occurring condition. This level of expertise is needed to conduct the thorough risk–benefit analysis needed for this complex patient population. ASAM and AAAP will continue to monitor the evolving evidence on this topic and update the recommendations as appropriate. Though both desirable and undesirable effects are small, mixing adderall and alcohol: a fatal combination based on the meta-analysis the CGC concluded that the potential benefits of bupropion outweigh the potential risks. Especially in the context of the lack of strongly supported medication alternatives, the CGC agreed that bupropion may be considered as a pharmacotherapeutic option for cocaine use disorder. The CGC expressed concern over the use of standalone technology-delivered interventions.

Amphetamines are illegal when they are used without a prescription to get high or improve performance. In this case, they are known as street, or recreational drugs, and using them can lead to addiction. Once you’ve been addicted to a drug, you’re at high risk of falling back into a pattern of addiction. If you do start using the drug, it’s likely you’ll lose control over its use again — even if you’ve had treatment and you haven’t used the drug for some time. The best way to prevent an addiction to a drug is not to take the drug at all. If your health care provider prescribes a drug with the potential for addiction, use care when taking the drug and follow instructions.